Clostridioides difficile infection epidemiology during the COVID-19 pandemic in Greece

Future Microbiol. 2024 Sep;19(13):1119-1127. doi: 10.1080/17460913.2024.2358653. Epub 2024 Jun 24.

Abstract

Aim: The aim was to highlight the incidence and epidemiology of C. difficile infections (CDI) in a tertiary Greek hospital during the COVID-19 pandemic.Methods: A single-center prospective observational cohort study was conducted (October 2021 until April 2022). 125 C. difficile isolates were cultured from hospitalized patients stool samples and screened by PCR for toxin A (tcdA), toxin B (tcdB), binary toxin (cdtA and cdtB) genes and the regulating gene of tcdC.Results: The incidence of CDI increased to 13.1 infections per 10,000 bed days. The most common PCR ribotypes identified included hypervirulent RT027-related RT181 (73.6%), presumably hypervirulent RT126 (8.0%) and toxin A negative RT017 (7.2%).Conclusion: Although the incidence of CDI increased significantly, the CDI epidemiology remained stable.

Keywords: Clostridioides difficile infection; PCR ribotyping; SARS-CoV-2; coronavirus disease 2019 pandemic; toxin genes profile.

Plain language summary

[Box: see text].

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bacterial Proteins / genetics
  • Bacterial Toxins / genetics
  • COVID-19* / epidemiology
  • Clostridioides difficile* / classification
  • Clostridioides difficile* / genetics
  • Clostridioides difficile* / isolation & purification
  • Clostridium Infections* / epidemiology
  • Clostridium Infections* / microbiology
  • Enterotoxins / genetics
  • Feces / microbiology
  • Feces / virology
  • Female
  • Greece / epidemiology
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pandemics
  • Prospective Studies
  • Ribotyping
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification
  • Tertiary Care Centers / statistics & numerical data

Substances

  • Bacterial Toxins
  • Bacterial Proteins
  • Enterotoxins